Stay updated on VX-445 in Cystic Fibrosis: Clinical Trial
Sign up to get notified when there's something new on the VX-445 in Cystic Fibrosis: Clinical Trial page.

Latest updates to the VX-445 in Cystic Fibrosis: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added; the government funding lapse notice and operating status details were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding lapse notice and updated site revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a glossary toggle and new entries for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the site revision updated to v3.4.0. The previous labels and version <u>v3.3.4</u> were removed in this update.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; this appears to be a minor maintenance update with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section listing study sites by state/country (Arizona, Arkansas, California, Colorado, Florida, Georgia, Illinois, Indiana, Kansas, Louisiana, Michigan, Minnesota, New Jersey, New Mexico, Ohio, Texas, Vermont, Virginia, Wisconsin, Victoria). Removed HHS Vulnerability Disclosure and updated the revision to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedPublications section updated to clarify that PubMed auto-fills publications and shows revision v3.3.2. Previously, the language referenced PubMed generation and revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to VX-445 in Cystic Fibrosis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-445 in Cystic Fibrosis: Clinical Trial page.